Synta Pharma (SNTA) Preclinical Shows STA-9090 Inhibits Wilms' Tumor 1 Protein
Tweet Send to a Friend
Synta Pharmaceuticals Corp. (NASDAQ: SNTA) today announced that preclinical results presented at the "Bridging the Gap 2010" Hematologic Conference, held ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


